{"title":"基于加速器的硼中子俘获治疗胸部肿瘤的可行性研究:治疗计划方面","authors":"Mihiro Takemori , Satoshi Nakamura , Tetsu Nakaichi , Hiroki Nakayama , Yasunori Shuto , Yuta Kobayashi , Miki Yonemura , Hana Endo , Homare Murata , Hiroyuki Okamoto , Takahito Chiba , Masato Nishitani , Shuka Nishina , Masaru Nakamura , Toshimitsu Hayashi , Tairo Kashihara , Hiroshi Igaki","doi":"10.1016/j.apradiso.2025.111835","DOIUrl":null,"url":null,"abstract":"<div><div>This study discusses the feasibility of accelerator-based boron neutron capture therapy (AB-BNCT) for thoracic cancers. Fourteen patients were enrolled: six with breast cancer, five with lung cancer, and three with esophageal cancer. Although BNCT is performed with a single fraction from a single beam direction, two-fraction treatments with different beam angles were considered to improve the dose of gross tumor volume (GTV) in cases where the dose constraint of GTV was not achieved. Relative biological effectiveness (RBE)-weighted dose distributions were calculated based on computed tomography (CT) images via Monte Carlo simulation (PHITS) to evaluate the dose to GTV and organs-at-risk (OARs). One-field irradiation plans in six patients (breast: 1, lung: 4, esophageal: 1) did not achieve the dose constraint of GTV owing to deep-seated or large tumors, whereas those in the other patients did. Among these six patients, the two-field irradiation plan improved the achievement rate of the dose constraint of GTV from zero to five patients and that of heart from five to six patients. Moreover, the 2-field irradiation plan improved the homogeneity index of GTV. Changing the appropriate dose prescription and number of treatment fractions according to the patient's condition can enhance the safe delivery of BNCT for thoracic cancers while delivering a sufficient dose to the tumors.</div></div>","PeriodicalId":8096,"journal":{"name":"Applied Radiation and Isotopes","volume":"221 ","pages":"Article 111835"},"PeriodicalIF":1.6000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Feasibility study of accelerator-based boron neutron capture therapy for thoracic tumors: treatment planning aspect\",\"authors\":\"Mihiro Takemori , Satoshi Nakamura , Tetsu Nakaichi , Hiroki Nakayama , Yasunori Shuto , Yuta Kobayashi , Miki Yonemura , Hana Endo , Homare Murata , Hiroyuki Okamoto , Takahito Chiba , Masato Nishitani , Shuka Nishina , Masaru Nakamura , Toshimitsu Hayashi , Tairo Kashihara , Hiroshi Igaki\",\"doi\":\"10.1016/j.apradiso.2025.111835\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This study discusses the feasibility of accelerator-based boron neutron capture therapy (AB-BNCT) for thoracic cancers. Fourteen patients were enrolled: six with breast cancer, five with lung cancer, and three with esophageal cancer. Although BNCT is performed with a single fraction from a single beam direction, two-fraction treatments with different beam angles were considered to improve the dose of gross tumor volume (GTV) in cases where the dose constraint of GTV was not achieved. Relative biological effectiveness (RBE)-weighted dose distributions were calculated based on computed tomography (CT) images via Monte Carlo simulation (PHITS) to evaluate the dose to GTV and organs-at-risk (OARs). One-field irradiation plans in six patients (breast: 1, lung: 4, esophageal: 1) did not achieve the dose constraint of GTV owing to deep-seated or large tumors, whereas those in the other patients did. Among these six patients, the two-field irradiation plan improved the achievement rate of the dose constraint of GTV from zero to five patients and that of heart from five to six patients. Moreover, the 2-field irradiation plan improved the homogeneity index of GTV. Changing the appropriate dose prescription and number of treatment fractions according to the patient's condition can enhance the safe delivery of BNCT for thoracic cancers while delivering a sufficient dose to the tumors.</div></div>\",\"PeriodicalId\":8096,\"journal\":{\"name\":\"Applied Radiation and Isotopes\",\"volume\":\"221 \",\"pages\":\"Article 111835\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Applied Radiation and Isotopes\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0969804325001800\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, INORGANIC & NUCLEAR\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Radiation and Isotopes","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0969804325001800","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
Feasibility study of accelerator-based boron neutron capture therapy for thoracic tumors: treatment planning aspect
This study discusses the feasibility of accelerator-based boron neutron capture therapy (AB-BNCT) for thoracic cancers. Fourteen patients were enrolled: six with breast cancer, five with lung cancer, and three with esophageal cancer. Although BNCT is performed with a single fraction from a single beam direction, two-fraction treatments with different beam angles were considered to improve the dose of gross tumor volume (GTV) in cases where the dose constraint of GTV was not achieved. Relative biological effectiveness (RBE)-weighted dose distributions were calculated based on computed tomography (CT) images via Monte Carlo simulation (PHITS) to evaluate the dose to GTV and organs-at-risk (OARs). One-field irradiation plans in six patients (breast: 1, lung: 4, esophageal: 1) did not achieve the dose constraint of GTV owing to deep-seated or large tumors, whereas those in the other patients did. Among these six patients, the two-field irradiation plan improved the achievement rate of the dose constraint of GTV from zero to five patients and that of heart from five to six patients. Moreover, the 2-field irradiation plan improved the homogeneity index of GTV. Changing the appropriate dose prescription and number of treatment fractions according to the patient's condition can enhance the safe delivery of BNCT for thoracic cancers while delivering a sufficient dose to the tumors.
期刊介绍:
Applied Radiation and Isotopes provides a high quality medium for the publication of substantial, original and scientific and technological papers on the development and peaceful application of nuclear, radiation and radionuclide techniques in chemistry, physics, biochemistry, biology, medicine, security, engineering and in the earth, planetary and environmental sciences, all including dosimetry. Nuclear techniques are defined in the broadest sense and both experimental and theoretical papers are welcome. They include the development and use of α- and β-particles, X-rays and γ-rays, neutrons and other nuclear particles and radiations from all sources, including radionuclides, synchrotron sources, cyclotrons and reactors and from the natural environment.
The journal aims to publish papers with significance to an international audience, containing substantial novelty and scientific impact. The Editors reserve the rights to reject, with or without external review, papers that do not meet these criteria.
Papers dealing with radiation processing, i.e., where radiation is used to bring about a biological, chemical or physical change in a material, should be directed to our sister journal Radiation Physics and Chemistry.